White Paper-The Vigiis 101-LAB, provides bodywide microbiome benefits with just one ingredient

201705608 final.

This white paper will expose the remaining untapped market potential for probiotics, as well as the role Vigiis® 101-LAB can play in meeting consumer needs for complete probiotic support across the microbiome.

   •  USD $78.3 billion will be reached by global probiotics market in 2026

   •   Constipation affecting 16% of US adults and 33% of US seniors

  •  COVID-19 has rocketed sales of immune health supplements up 25 percent in 2020, with expected impact in probiotics.